For instance, mutant KRAS-driven pancreatic cancer cells, which rely on glutamine metabolism to support their growth, can maintain proliferation under glutamine-limiting conditions if supplied with extracellular serum albumin. Here, KRAS is linked to pancreatic neoplasm.